why-v2

AstraZeneca’s RPA Director Discusses Measuring Automation ROI and Scaling RPA vs. AI

As part of our Practitioner Perspectives interview series that is focused on giving you first-hand insight into best practices from expert practitioners who are leading automation and digital transformation programs, AstraZeneca’s RPA Director Peter Guess, recently joined IRPA AI’s President of Media & Events, to explore:

– The current priorities around RPA & AI at AstraZeneca
– The difference in scaling RPA vs. AI
– How to measure ROI for your automation projects

 

 

 

 

 

 

 

Leave a Reply

Featured Content

Latest News

Join The IRPA NETWORK

Are you ready to take the first step and learn more about RPA?

Contact Us